|
Adult patient:
Minimum blood volume: 3 mL |
||||||||||||||||||||||
|
Paediatric patient: Paediatric EDTA tube Number of vials: 1 Minimum blood volume: 1.3 mL |
||||||||||||||||||||||
|
Authorisation code required |
No |
|||||||||||||||||||||
|
24 Hr available service |
No |
|||||||||||||||||||||
| Precaution | Trough level monitoring (pre-dose) | |||||||||||||||||||||
|
Method |
Liquid chromatography-tandem mass spectrometry |
|||||||||||||||||||||
|
Reference interval |
Target trough concentration (µg/L):
(Source: Ther Drug Monit 2009; 31: 139 - 152) |
|||||||||||||||||||||
|
Clinical indication |
Therapeutic drug monitoring in patients receiving tacrolimus (FK506) therapy to avoid rejection of organ transplants and to detect toxic levels. |
|||||||||||||||||||||
|
Result interpretation |
An elevated result provides an early indication of the possibility of toxicity. |
|||||||||||||||||||||
|
Measurement of uncertainty |
||||||||||||||||||||||
|
Frequency of measurement |
Twice weekly |